Axio Biosolutions Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Axio Biosolutions's estimated annual revenue is currently $34.6M per year.
- Axio Biosolutions's estimated revenue per employee is $251,000
- Axio Biosolutions has 138 Employees.
- Axio Biosolutions grew their employee count by 6% last year.
- Axio Biosolutions currently has 1 job openings.
What Is Axio Biosolutions?
Axio is a deep science medtech company focused on Advanced Surgical, Trauma and woundcare. Makers of India's first USFDA cleared hemostat - AXIOSTAT (a patented, Fda 510k and CE approved medical device made from 100% Chitosan) and MaxioCel (a chitosan microfiber dressing for Diabetic foot ulcers and other chronic ulcers) Axio develops and commercializes active medical products using novel biomaterials for advanced woundcare. We believe in creating value by delivering affordable solutions for unmet health care needs.keywords:Healthcare, Medical Devices, Defense, Hospitals